Franklin Resources Inc Cabaletta Bio, Inc. Transaction History
Franklin Resources Inc
- $346 Billion
- Q3 2024
Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
142Shares Held
49.3MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.63MShares$24.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$20.9 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$17 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$13.3 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$11.5 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $127M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...